PlumX Metrics
Embed PlumX Metrics

New anti-HSV therapeutics target the helicase-primase complex

Nature Medicine, ISSN: 1078-8956, Vol: 8, Issue: 4, Page: 327-328
2002
  • 46
    Citations
  • 0
    Usage
  • 18
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Article Description

The only targets for clinical treatment of herpes simplex virus infections have been the viral enzymes thymidine kinase and DNA polymerase. Now, animal experiments show the healing benefits of new antiherpes drugs that act on the viral helicase-primase complex and appear superior to the standard treatment, acyclovir.

Bibliographic Details

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know